The pacemaker market is estimated to achieve USD 5.1 billion by 2024 from USD 4.3 billion in 2017, at a CAGR of 2.1%. Pacemakers are medical devices that regulate the rate at which the heart’s chambers pump blood and are meant for persons who suffer irregular heartbeats. This can be caused by several variables, including environmental, genetic, and behavioural factors, or a combination of them.
Pacemakers are linked to longer lifespans and life expectancies in persons who have them implanted. On the other hand, electronic pacemakers are related to several issues, including their size. Even though current units can be as little as a grain of rice, some users find them difficult to wear. Pacemakers, as well as the wires that connect them to their power supplies, are implanted in the chest. This configuration increases the risk of pacemaker issues, including an infection or irritation around the wires, sometimes known as ‘leads’ and sudden battery failures. There are also cases of pacemaker lead corrosion and product recalls, both of which have resulted in impromptu pacemaker removal procedures for patients with who any of these potentially deadly situations has afflicted. Even if the pacemaker works well and has no side effects, the battery will eventually wear out and need to be changed, which generally necessitates additional surgery.
To overcome these limitations for millions of individuals worldwide, battery-free implants might reduce the costs, medical hazards & inconvenience of having to replace a battery every 5 to 12 years.
Battery-Free Pacemakers:
Rice University and THI-Texas Heart Institute researchers have developed a wireless and battery-free pacemaker that may be placed directly into a patient’s heart. Their device was presented at the IEEE’s International Microwave Symposium (IMS) in Honolulu.
University at Buffalo School of Engineering and Applied Sciences is creating a piezoelectric system that converts vibrational energy–created inside the chest by each heartbeat – into electricity, which is then utilized to operate the pacemaker.
For the complete in-depth article on ‘Battery-Free Implantable Pacemakers’, please visit @ https://www.iebrain.com/next-generation-battery-free-implantable-pacemakers/
About Ingenious e-Brain Solutions: -
Ingenious e-Brain Solutions provides high-quality, customized, and cost-effective Technology Intelligence, Business Intelligence, and Intellectual Property Intelligence solutions to industry leaders, and innovative companies across the globe. Innovation, knowledge, and transparency form the basis of our company’s mission and vision. Along with cost benefits, we provide highest quality results ensuring fool-proof confidentiality and security. We are an ISO certified company with offices in India and USA.
Ingenious e-Brain Solutions has a strong team of analysts, and subject matter experts with domain proficiency which is devoted to help clients grow. Our highly qualified professionals offer tailored, value-added and cost-effective services to our clients. We believe in building long term relationships with our clients who include national and international corporations, Fortune 500 companies, world’s leading research institutes and universities as well as independent inventors.
Get in Touch: -
India Office
207-208 Welldone TechPark, Sohna Road
Sector 48, Gurugram, Haryana 122018, India
+91 124 429 4218
Email: -
According to a new market research report Pacemakers Market by Implantability (External), Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), Type (Conventional, MRI Compatible), End Users (Hospitals and Cardiac Centers, Ambulatory Surgery Center) - Global Forecast to 2027, is projected to reach USD 5.3 billion by 2023 from USD 4.5 billion in 2019, at a CAGR of 2.0%.
Growth in this market is driven by increasing prevalence of cardiovascular diseases and technological advancements in devices.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243344814 Browse and in-depth TOC on "Pacemakers Market"114 - Tables24- Figures122 - PagesThe implantable pacemakers segment, by implantability, projected to occupy the majority of the market share and grow at the fastest rate during the forecast period.The implantable pacemakers segment is projected to be the fastest-growing segment, by implantability, during the forecast period.
The large share of the implantable pacemakers segment is primarily attributed to the increasing prevalence of CVDs and the rising preference for these pacemakers due to their benefits over their external counterparts.The MRI compatible pacemakers segment, by livestock, is projected to occupy the majority of the market share and grow at the fastest rate during the forecast period.The MRI compatible pacemakers segment is projected to be the fastest-growing segment, by type, during the forecast period.
This can be attributed to the growing number of patients with implanted pacemakers and the increasing need for MRI scans in the geriatric population, as patients in this age group are more likely to have cardiac devices such as pacemakers.North America is projected to account for the largest market size in the pacemakers market during the forecast period.North America is estimated to account for the largest share of the market.
Factors such as the rising prevalence of CVDs, growing geriatric population, increasing healthcare expenditure, and the availability of technologically advanced devices are driving the growth of the pacemakers market in North America.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=243344814 Major vendors in the pacemakers market include Medtronic (Ireland), Abbott (US), and Boston Scientific (US), BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China).About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues.
Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.
